Insider Selling: Omada Health (NASDAQ:OMDA) CEO Sells 17,258 Shares of Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 17,258 shares of the business’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $20.68, for a total transaction of $356,895.44. Following the transaction, the chief executive officer directly owned 382,594 shares of the company’s stock, valued at approximately $7,912,043.92. This trade represents a 4.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Omada Health Price Performance

Shares of OMDA stock traded up $0.58 during trading hours on Monday, reaching $20.95. The stock had a trading volume of 747,067 shares, compared to its average volume of 1,277,139. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92. The firm has a 50-day simple moving average of $21.80 and a 200-day simple moving average of $18.68. The firm has a market capitalization of $1.28 billion, a PE ratio of 419.00 and a beta of 2.03.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The firm had revenue of $87.83 million during the quarter, compared to analyst estimates of $80.93 million. On average, equities analysts anticipate that Omada Health, Inc. will post 0.09 earnings per share for the current year.

Institutional Trading of Omada Health

A number of large investors have recently added to or reduced their stakes in OMDA. WINTON GROUP Ltd acquired a new stake in shares of Omada Health during the 2nd quarter valued at $1,101,000. Integrated Wealth Concepts LLC acquired a new position in shares of Omada Health in the 2nd quarter worth $53,000. Squarepoint Ops LLC acquired a new position in shares of Omada Health in the 2nd quarter worth $2,044,000. Corient Private Wealth LP raised its position in shares of Omada Health by 252.5% during the second quarter. Corient Private Wealth LP now owns 145,118 shares of the company’s stock worth $3,185,000 after purchasing an additional 103,955 shares during the period. Finally, Round Rock Advisors LLC purchased a new stake in shares of Omada Health during the second quarter valued at $745,000.

Analyst Ratings Changes

A number of equities analysts recently issued reports on OMDA shares. Barclays increased their price objective on Omada Health from $25.00 to $27.00 and gave the stock an “overweight” rating in a report on Friday, September 11th. BMO Capital Markets reiterated an “outperform” rating and set a $24.00 price target on shares of Omada Health in a research report on Friday, August 7th. Wall Street Zen cut Omada Health from a “buy” rating to a “hold” rating in a research note on Saturday. Morgan Stanley reissued an “overweight” rating and set a $30.00 price target on shares of Omada Health in a report on Monday, June 22nd. Finally, Citizens Jmp increased their target price on shares of Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a research report on Friday, August 14th. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $26.67.

About Omada Health

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines connected health devices, digital tools, health coaching and clinical support to help members improve their health and manage conditions such as diabetes, hypertension and musculoskeletal disorders.

The company’s services are designed for employers, health plans and other healthcare organizations seeking to support populations with ongoing healthcare needs.